Campbell & Co Investment Adviser’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $439K | Buy |
+46,829
| New | +$439K | 0.03% | 835 |
|
|
2024
Q3 | – | Sell |
-33,123
| Closed | -$680K | – | 1312 |
|
|
2024
Q2 | $680K | Buy |
+33,123
| New | +$680K | 0.06% | 528 |
|
|
2020
Q1 | – | Sell |
-44,838
| Closed | -$394K | – | 452 |
|
|
2019
Q4 | $394K | Buy |
+44,838
| New | +$394K | 0.12% | 315 |
|
|
2019
Q3 | – | Sell |
-39,372
| Closed | -$367K | – | 756 |
|
|
2019
Q2 | $367K | Buy |
+39,372
| New | +$367K | 0.17% | 238 |
|